INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 138 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $265,000 | +10.0% | 18,045 | 0.0% | 0.07% | 0.0% |
Q3 2019 | $241,000 | -18.3% | 18,045 | 0.0% | 0.07% | -28.7% |
Q2 2019 | $295,000 | -4.2% | 18,045 | 0.0% | 0.09% | -12.1% |
Q1 2019 | $308,000 | +25.2% | 18,045 | 0.0% | 0.11% | -28.7% |
Q4 2018 | $246,000 | -72.8% | 18,045 | -42.8% | 0.15% | -35.3% |
Q3 2018 | $903,000 | +4.6% | 31,545 | 0.0% | 0.23% | -6.8% |
Q2 2018 | $863,000 | +180.2% | 31,545 | +96.9% | 0.25% | +139.4% |
Q4 2017 | $308,000 | – | 16,020 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |